American Century Companies’s Ginkgo Bioworks DNA Stock Holding History

American Century Companies's DNA Position: Q2 2026 in Review

American Century Companies increased its Ginkgo Bioworks (DNA) stake by 13% in Q2 2026, buying an estimated $91.7K and bringing the position to 98,357 shares worth $975K. The position accounts for ﹤0.01% of the portfolio, ranked #2406.

American Century Companies first reported a position in DNA in Q2 2022 and has held it in 12 quarters since. The position peaked at $1.17M in Q3 2025. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

• American Century Companies held 98,357 shares of Ginkgo Bioworks worth $975K as of Q2 2026.
• American Century Companies bought 10,971 Ginkgo Bioworks shares in Q2 2026, an estimated $91.7K.
• Ginkgo Bioworks made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2406 holding.
• American Century Companies first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 12 quarters since.
• American Century Companies's Ginkgo Bioworks position peaked at $1.17M in Q3 2025.
• 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.